FDA clears new version of Boston Scientific's SpyGlass

Boston Scientific says the FDA cleared the SpyGlass DS version of its cholangioscopy and pancreatoscopy device.

Boston Scientific (NYSE:BSX) said the FDA granted 510(k) clearance for the latest iteration in its line of cholangioscopy and pancreatoscopy devices, the SpyGlass DS.

Boston Scientific, Food & Drug Administration (FDA)

News Well, 510(k), Biliatrics, Endoscopic / Arthroscopic, Regulatory/Compliance

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1zLn4Sn